跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SOGROYA 15 MG/1,5 ML SOLUCION INYECTABLE EN PLUMA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SOGROYA 15 MG/1,5 ML SOLUCION INYECTABLE EN PLUMA PRECARGADA
Approved
STANDARD
SOGROYA 15 MG/1,5 ML SOLUCION INYECTABLE EN PLUMA PRECARGADA
Novo Nordisk A/S
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 8, 2023
Approval ID
9d6ac436b86dce8c
Company
Novo Nordisk A/S
Type
Standard
Approval Details
Approval Id
9d6ac436b86dce8c
Drug Cima Aemps Name
SOGROYA 15 MG/1,5 ML SOLUCION INYECTABLE EN PLUMA PRECARGADA
Register Number
1201501005
Holder Company Name
Novo Nordisk A/S
Marketing Company Name
Novo Nordisk Pharma S.A.
Holder Company Detail Path
/organization/novo-nordisk-a-s
Authorization Date
2023-11-08
Dosage Form
SOLUCIÓN INYECTABLE
Dose
15 MG
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Novo Nordisk A/S
Company Detail Path
/organization/novo-nordisk-a-s
Company Information
Pharmaceutical Company Name
Novo Nordisk A/S
Name En
Novo Nordisk A/S
Country Name
Denmark
City Name
bagsværd,hovedstaden,country_dk
Address
Novo Alle 1
Website
https://www.novonordisk.com
Active Ingredients
SOMAPACITAN
15 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 8, 2023
Approval ID
9d6ac436b86dce8c
Type
Standard
Back to CIMA-AEMPS Approvals